Tag: Neurological disorders

Originally developed as an antiviral for influenza, amantadine was serendipitously discovered in the 1960s to have beneficial effects on a neurological disorder, leading to its current use for Parkinson's disease and other movement-related conditions. This unique journey highlights its multipurpose nature in both infectious and neurological medicine.

Temporal Lobe Epilepsy (TLE) is the most common form of focal epilepsy in adults and is often resistant to treatment. The most common approach to addressing **what meds calm the temporal lobe** involves using antiseizure medications (AEDs) that work to stabilize the brain's electrical activity and control seizure frequency.

Affecting an estimated 1 in 1 million people, stiff-person syndrome is a rare neurological disorder that can cause severe, progressive muscle rigidity. This disabling symptom is not merely typical muscle soreness but a persistent, painful tightening that severely restricts movement and can arise from a wide range of issues, including complex pharmacological reactions, infections, and other serious medical conditions that impact the nervous system. The question of what causes extreme muscle rigidity has many answers, requiring a precise diagnosis for effective management.

In clinical trials, worsening pain with gabapentin was rare, reported in about 1% of patients—a rate similar to those on a placebo. However, some individuals still feel that **can gabapentin make nerve issues worse**, and understanding the reasons behind this perception is crucial for effective treatment management.

While baclofen is prescribed to reduce muscle spasticity, a sudden appearance of new or worsening muscle activity, including twitches, is a reported side effect. This raises the question: **can baclofen cause muscle twitches**? Yes, primarily as a result of abrupt withdrawal or, in more severe cases, toxicity.

While corticosteroids are often used to treat inflammation, a well-documented but rare side effect is the development of benign intracranial hypertension, a condition where **steroids can cause increased intracranial pressure**. This elevated pressure, also known as pseudotumor cerebri, frequently manifests during dose reduction or withdrawal of the medication, not during treatment.

Visual hallucinations occur in up to 75% of people with Parkinson's disease over the course of their illness. To determine what is the best medicine for Parkinson's hallucinations, doctors first rule out other causes and may adjust dopamine-boosting drugs before turning to antipsychotics specifically designed for this condition, such as pimavanserin.

Drug-induced parkinsonism (DIP) is the second most common cause of parkinsonism after idiopathic Parkinson's disease (PD) [1.7.4]. This article explores the critical question: **how long does drug-induced Parkinson's last** and what does the path to recovery entail?

In 1995, Riluzole (marketed as Rilutek) became the first FDA-approved medication for the treatment of Amyotrophic Lateral Sclerosis (ALS). The medication works primarily by inhibiting the activity of glutamate, a major excitatory neurotransmitter in the central nervous system. By interfering with glutamatergic signaling, the drug helps to reduce the neurotoxicity believed to contribute to the progressive nerve cell damage seen in ALS.

Approximately 1.5% to 15% of people have vitamin B12 deficiency, and for those with an inability to absorb the vitamin, injections are the required treatment. A medical diagnosis is the first step in understanding **how do you qualify for B12 injections** and determining the underlying cause of your deficiency. Injections are reserved for specific medical and dietary reasons, ensuring the vital nutrient is properly delivered to the bloodstream.